Andrew: Back in Jan you had written <<I think very highly of this team's ability to build and manage a theater business>> An impression I found reinforced by several knowledgeable posters on Yahoo...so what's with the GISH position: "GISH BIOMEDICAL, INC. SHAREHOLDER FILES SEC FORM 4 WASHINGTON, DC, Apr. 29, 1999 (States via COMTEX) -- Craig Corp. of Los Angeles, CA, a Shareholder of Gish Biomedical, Inc. (SYMBOL: GISH), accumulated 60,800 shares in 4 transactions for between $2.53 - $2.75 each between March 02, 1999 and M arch 16, 1999. Craig Corp. currently owns 459,650 shares. A Form 4 reporting the transaction was filed with the Securities and Exchange Commission on April 13, 1999." [CDL made similar accum. of GISH] What does a theater guy know about cardiac devices? I recall a group mentioning that buttery movie popcorn clogged arteries...are they gonna offer these in the lobby to offset the damage <g>? Cash per share is big attraction here...If they know the theater biz and expand on what looks like a viable niche strategy in art and under covered areas, Aus, this makes sense. Buying stuff way out of expertise loop...especially complex techinical stuff that has no apparent fit is worrisome. There's no amount of cash that can't be frittered away when someone moves outside his circle of competence. Is there any reason to beleive Cotter and his team understand this business? |